[1] 张伟,许荣放,田锐锋,等.阿德福韦酯与替比夫定联合恩替卡韦对失代偿期乙肝肝硬化患者肝功能及血清病毒学指标的影响.解放军医学杂志, 2016,41: 1046-1047.
[2] 陈继梅,丁雪芳,许叶虹. 乙丙肝重叠感染者血清学及病毒学检测结果分析.中国实验诊断学, 2014,18: 651-652.
[3] Liaw YF, Chen YC, Sheen IS, et al. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.Gastroenterology, 2004,126:1024-1029.
[4] Biliotti E, Kondili LA, Furlan C, et al. Acute hepatitis B in patients with or without underlying chronic HCV infection. J Infect, 2008,57:152-157.
[5] 张伟.王九萍.直接抗病毒药物治疗丙型肝炎的安全性.中华传染病杂志, 2017,35:59-61.
[6] 刘玉风.谢雯.DAA时代,丙型肝炎治疗仍需努力, 2017,22:3-4.
[7] FDA Drug Safety Communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C. 2016-04-10. https://www.fda.gov/Drugs/DrugSafety/ucm522932.htm. |
